News ArchivesRead News

Your Weekly News Update for the Week of 12.16.19

Monday December 16, 2019
Cancer Drug May Ease Symptoms of Parkinson's
Georgetown researchers found that most participants in this clinical trial not only tolerated but experienced symptom relief from the drug nilotinib (brand name: Tasigna). A treatment for cancer, this drug increased production of dopamine and halted decline in motor function.
Molecular Bodyguards Against Parkinson's
Medical Xpress
"It is well accepted that the protein α-Synuclein can play a key role in the development of Parkinson's. Researchers led by structural biologist Prof. Sebastian Hiller have now discovered that assisting proteins, known as chaperones, are constantly protecting α-Synuclein in human cells. Whenever the chaperones are unable to fulfill their bodyguard job, α-Synuclein shows its negative side and causes serious cell damage."
Symptom Control of Parkinson's
Linked to Ability, Productivity of Employment
AJMC Network
This article indicates the importance of accommodating Parkinson's symptoms in the workplace as well as symptom management. It also summarizes findings from the Fox Foundation's 2019 report of the economic burden of Parkinson's.